McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368
Article CAS PubMed Google Scholar
Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391(10120):572–580. https://doi.org/10.1016/S0140-6736(17)32520-5
Article PubMed PubMed Central Google Scholar
Straw S, McGinlay M, Gierula J, Lowry JE, Paton MF, Cole C et al (2021) Impact of QRS duration on left ventricular remodelling and survival in patients with heart failure. J Cardiovasc Med (Hagerstown) 22(11):848–856. https://doi.org/10.2459/JCM.0000000000001231
Breidthardt T, Christ M, Matti M, Schrafl D, Laule K, Noveanu M et al (2007) QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure. Heart 93(9):1093–1097. https://doi.org/10.1136/hrt.2006.102319
Article CAS PubMed PubMed Central Google Scholar
Lund LH, Jurga J, Edner M, Benson L, Dahlstrom U, Linde C et al (2013) Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J 34(7):529–539. https://doi.org/10.1093/eurheartj/ehs305
Article CAS PubMed Google Scholar
Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J et al (2013) An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 34(46):3547–3556. https://doi.org/10.1093/eurheartj/eht290
Article PubMed PubMed Central Google Scholar
Ding WY, Cooper R, Todd D, Gupta D, Hall M, Rao A et al (2018) Natural progression of QRS duration in ICD-only patients. J Interv Card Electrophysiol 53(1):47–51. https://doi.org/10.1007/s10840-018-0394-3
Linde CM, Normand C, Bogale N, Auricchio A, Sterlinski M, Marinskis G et al (2018) Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European society of cardiology CRT survey II. Eur J Heart Fail 20(10):1457–1468. https://doi.org/10.1002/ejhf.1235
Schwertner WR, Behon A, Merkel ED, Tokodi M, Kovacs A, Zima E et al (2021) Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience. Europace 23(8):1310–1318. https://doi.org/10.1093/europace/euab059
Article PubMed PubMed Central Google Scholar
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28(1):1-39e14. https://doi.org/10.1016/j.echo.2014.10.003
Team RC (2020) R: a language and environment for statistical computing. R Foundation for Statistical Computing. https://www.R-project.org/
Sandhu R, Bahler RC (2004) Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol 93(2):244–246. https://doi.org/10.1016/j.amjcard.2003.09.053
Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN, Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart F (2002) QRS duration and mortality in patients with congestive heart failure. Am Heart J 143(6):1085–1091. https://doi.org/10.1067/mhj.2002.122516
Kalra PR, Sharma R, Shamim W, Doehner W, Wensel R, Bolger AP et al (2002) Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 86(2–3):225–231. https://doi.org/10.1016/s0167-5273(02)00270-x
Xiao HB, Roy C, Fujimoto S, Gibson DG (1996) Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 53(2):163–170. https://doi.org/10.1016/0167-5273(95)02502-2
Article CAS PubMed Google Scholar
Chen X, Hansson PO, Thunstrom E, Mandalenakis Z, Caidahl K, Fu M (2021) Incremental changes in QRS duration as predictor for cardiovascular disease: a 21-year follow-up of a randomly selected general population. Sci Rep 11(1):13652. https://doi.org/10.1038/s41598-021-93024-y
Article CAS PubMed PubMed Central Google Scholar
Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY (2002) Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart 88(1):47–51. https://doi.org/10.1136/heart.88.1.47
Article CAS PubMed PubMed Central Google Scholar
Lin YJ, Liu YB, Chu CC (2009) Incremental changes in QRS duration predict mortality in patients with atrial fibrillation. Pacing Clin Electrophysiol 32(11):1388–1394. https://doi.org/10.1111/j.1540-8159.2009.02508.x
Karikari Y, Abdulkarim M, Li Y, Loomba RS, Zimmerman F, Husayni T (2020) The progress and significance of QRS duration by electrocardiography in hypoplastic left heart syndrome. Pediatr Cardiol 41(1):141–148. https://doi.org/10.1007/s00246-019-02237-6
Daubert MA, Adams K, Yow E, Barnhart HX, Douglas PS, Rimmer S et al (2019) NT-proBNP goal achievement is associated with significant reverse remodeling and improved clinical outcomes in HFrEF. JACC Heart Fail 7(2):158–168. https://doi.org/10.1016/j.jchf.2018.10.014
Naqvi SY, Jawaid A, Vermilye K, Biering-Sorensen T, Goldenberg I, Zareba W et al (2019) Left ventricular reverse remodeling in cardiac resynchronization therapy and long-term outcomes. JACC Clin Electrophysiol 5(9):1001–1010. https://doi.org/10.1016/j.jacep.2019.07.012
Mathew J, Katz R, St John Sutton M, Dixit S, Gerstenfeld EP, Ghio S et al (2012) Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study. Eur J Heart Fail 14(12):1420–1428. https://doi.org/10.1093/eurjhf/hfs135
Article PubMed PubMed Central Google Scholar
O’Sullivan CA, Henein MY, Sutton R, Coats AJ, Sutton GC, Gibson DG (1998) Abnormal ventricular activation and repolarisation during dobutamine stress echocardiography in coronary artery disease. Heart 79(5):468–473. https://doi.org/10.1136/hrt.79.5.468
Article CAS PubMed PubMed Central Google Scholar
Holmstrom L, Haukilahti A, Vahatalo J, Kentta T, Appel H, Kiviniemi A et al (2020) Electrocardiographic associations with myocardial fibrosis among sudden cardiac death victims. Heart 106(13):1001–1006. https://doi.org/10.1136/heartjnl-2019-316105
Article CAS PubMed Google Scholar
Stewart RA, Young AA, Anderson C, Teo KK, Jennings G, Cowan BR (2011) Relationship between QRS duration and left ventricular mass and volume in patients at high cardiovascular risk. Heart 97(21):1766–1770. https://doi.org/10.1136/heartjnl-2011-300297
Dhingra R, Ho Nam B, Benjamin EJ, Wang TJ, Larson MG, D’Agostino RB Sr et al (2005) Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham heart study. J Am Coll Cardiol 45(5):685–689. https://doi.org/10.1016/j.jacc.2004.11.046
留言 (0)